← Leaderboards
Scott Andrew Gerber
University Of Rochester
$4,201,154
Attributed
$6,418,560
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,418,560 · 5
By mechanism
R01$5,887,879 · 4
T32$530,681 · 1
Top collaborators
- David C Linehan4 shared
- Elizabeth Repasky3 shared
- Jacques Robert2 shared
- Darren Richard Carpizo1 shared
Most similar at University Of Rochester
Same institution · by research overlap
- David C Linehan$5,269,651
- Raymond L Konger$2,583,958
- Nicholas Cohen$3,162,866
- Edith M. Lord$14,314,079
Others in their field
Other Emerging Leaders on “Tumor”
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
- Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
- Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
TumorTumor MicroenvironmentMediatingInnovationNeoplasm MetastasisImmune ResponseImmunotherapyRadiation TherapyClinically RelevantPre-ClinicalMalignant NeoplasmsResearch PersonnelCessation Of LifeImmuneEncapsulatedDistalEffective TherapyCellsImmunosuppressionPrimary NeoplasmMyeloid CellsCytokineInterleukin-12Immune System
Grant awards (15)
Targeting Intrinsic and Extrinsic Barriers to Treat Metastatic Pancreatic Cancer$639,098
R01 · FY2025 · CA · contact PI
The T32 Predoctoral Training Program in Immunology (PTPI)$269,505
T32 · FY2025 · AI
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer$83,487
R01 · FY2025 · CA · contact PI
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer$490,237
R01 · FY2024 · CA · contact PI
The T32 Predoctoral Training Program in Immunology (PTPI)$261,176
T32 · FY2024 · AI
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response$549,341
R01 · FY2023 · CA
Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer$392,242
R01 · FY2023 · CA · contact PI
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response$549,341
R01 · FY2022 · CA
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer$516,038
R01 · FY2022 · CA · contact PI
Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer$392,238
R01 · FY2022 · CA · contact PI
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response$560,552
R01 · FY2021 · CA
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer$516,038
R01 · FY2021 · CA · contact PI
Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer$400,246
R01 · FY2021 · CA · contact PI
Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer$400,246
R01 · FY2020 · CA · contact PI
Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer$398,775
R01 · FY2019 · CA · contact PI